Avania Clinical

Brunswick, Australia Founded: 1988 • Age: 38 yrs Acquired By Astorg Partners
Regulatory, clinical trials, and analytic services are provided in healthcare.

About Avania Clinical

Avania Clinical is a Healthcare company based in Brunswick (Australia) founded in 1988, and was acquired by Astorg Partners in June 2022. Regulatory, clinical trials, and analytic services are provided in healthcare. The company has 147 employees. Avania Clinical has completed 6 acquisitions, including Anagram Esic, Hull Associates and Imarc Research. Avania Clinical offers products and services including Strategic Consulting, Clinical Operations, and Data Analytics. Its focus areas include Biopharma Outsourcing and Diversified.

Company details

Avania was established in 1988 in Brunswick, Australia, within the clinical research sector. Regulatory compliance, clinical trial management, and data analytics services are delivered to pharmaceutical and medical device firms. Support is extended for trial design, execution, and regulatory submissions across various therapeutic areas. Operations are centered in Australia, with capabilities to address global client requirements in a structured manner.

Key Metrics

Products & Services of Avania Clinical

Avania Clinical offers a comprehensive portfolio of products and services, including Strategic Consulting, Clinical Operations, and Data Analytics.

Strategic Consulting
Consulting Services

Offers regulatory and development strategies for medical technologies.

Clinical Operations
Operational Services

Manages trials and data for medical device advancements.

Data Analytics
Analytics Services

Provides safety and compliance analysis for biotech products.

Funding Insights of Avania Clinical

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Avania Clinical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2016Private Equity Round–Kester Capital
–
Valuation history

2 investors in total: 2 institutional.

Investors in Avania Clinical

Avania Clinical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Kester Capital and Astorg.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Kester Capital is focused on private equity investments in technology and life sciences sectors.
kestercapital.comLondon, United Kingdom
Astorg is engaged in private equity investment management.
astorg.comParis, France
Premium access

Investor details for Avania Clinical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Avania Clinical

30 people are tracked at Avania Clinical (10 in leadership, 20 in team); the tracked headcount is 147.

NameRoleGroup
Deborah Bell
Executive Director, Business Development (AUS)Leadership
Anne Leijsen
Director, Medical WritingLeadership
Megan Williams (Yee)
Associate Director BiostatisticsLeadership
Jasmine Saba
Senior Vice President, Strategic RelationshipsLeadership
Aleksandra (Ola) Modrzejewska
Senior Director Legal & Company SecretaryLeadership
Elizabeth Kane
Director BiostatisticsLeadership
Sander L.
Global Director IT & Information SecurityLeadership
Sarah Robinson
Chief Human Resources OfficerLeadership
Sam Kasierski
Director Of Business DevelopmentLeadership
Hailey Jannetty
Associate Director, Customer SolutionsLeadership
Geerte Hoeke
Senior Medical WriterTeam
Amber Salomons
Principal Medical WriterTeam
Michael Adam Campbell
Legal CounselTeam
Els Beijer
Senior Medical WriterTeam
Frances Bach
Medical WriterTeam
Gala Garrod, PhD
Medical WriterTeam
Esther J. Smits
Senior Medical WriterTeam
Tjerk Zult, PhD
Senior Medical WriterTeam
Razieh Taghavi
Manager Biostatistics (eu & Aus)Team
Thomas Mouraviev
Information Technology Systems AdministratorTeam

10 more people are available in the full profile.

Premium access

Complete people profiles for Avania Clinical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Avania Clinical

Avania Clinical has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Anagram Esic, Hull Associates and Imarc Research.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Clinical trial services and imaging core lab support are provided.
anagram-esic.comBarcelona, Spain1998Oct 2024β€’β€’β€’β€’
Innovative medical devices and healthcare products are commercialized comprehensively.
ironstonepd.comToronto, Canada2013Oct 2023β€’β€’β€’β€’
Provider of market access and reimbursement consulting services for biopharma sector
hullassociates.comRockland, United States2007Oct 2023β€’β€’β€’β€’
Clinical research services are provided to medical device companies.
maxismedical.comSan Jose, United States2003Feb 2023β€’β€’β€’β€’
Foreign language courses are provided for all ages and levels.
imarcresearch.comStrongsville, United States1999Jun 2021β€’β€’β€’β€’
Healthcare consulting is specialized in for clinical and regulatory affairs.
milestonecro.comSan Diego, United States2011Oct 2017β€’β€’β€’β€’
Premium access

Complete acquisition details for Avania Clinical

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Avania Clinical

9 dated milestones of Avania Clinical across 36 years, from founding to its latest funding, stage changes and deals.

  1. Founded Avania Clinical is founded.
  2. Funding First funding round.
  3. Acquisition Acquires MileStone Research.
  4. Acquisition Acquires Imarc Research.
  5. Exit Acquired by Astorg Partners.
  6. Acquisition Acquires Maxis Medical.
  7. Acquisition Acquires Hull Associates.
  8. Acquisition Acquires Ironstone Product Development.
  9. Acquisition Acquires Anagram Esic.

Web traffic of Avania Clinical

The website of Avania Clinical (avaniaclinical.com) receives about 6.2K visits a month and ranks #4,326,087 among all websites worldwide, #5,305 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    6.2K

    ▲ 47.9% vs previous month

  • Unique visitors
    1.9K

    per month

  • Global rank
    #4,326,087

    among all websites

  • Category rank
    #5,305

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Avania Clinical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
zedmed.com.au
100%
#2,261,813View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Avania Clinical

Premium access

Complete news archive for Avania Clinical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avania Clinical

Avania Clinical was founded in 1988 and raised its 1st funding round 28 years after it was founded.

Avania Clinical is headquartered in Brunswick, Australia. It is registered at Brunswick, Victoria, Australia.

Avania Clinical has 147 employees.

Avania was established in 1988 in Brunswick, Australia, within the clinical research sector. Regulatory compliance, clinical trial management, and data analytics services are delivered to pharmaceutical and medical device firms. Support is extended for trial design, execution, and regulatory submissions across various therapeutic areas. Operations are centered in Australia, with capabilities to address global client requirements in a structured manner.

Avania Clinical offers Strategic Consulting, Clinical Operations, and Data Analytics.

Avania Clinical has made 6 acquisitions, including Anagram Esic, Hull Associates, and Imarc Research.

Avania Clinical has 2 investors. Key investors include Kester Capital, and Astorg.

Yes. Avania Clinical was acquired by Astorg Partners in June 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available